A chemiluminescence assay to detect antibodies to brain surface antigens in human sera.
A chemiluminescence assay was developed based on the interaction between antibodies binding to the surface of living brain cells in culture and macrophages. Such interaction leads to production of reactive oxygen radicals which can be measured by a chemiluminescence assay. This assay was used to detect anti brain antibodies in serum samples from humans with various neurological diseases. Such antibody activity was found in a high proportion of these patients. Subsequent experiments with purified IgG fractions and corresponding F(ab')2 fragments showed that the observed reactions were highly specific. It was concluded that the chemiluminescence assay is a sensitive and useful technique to detect autoantibodies in neurological diseases.
Brügger
M
M
Institute of Animal Neurology, University of Berne, Switzerland.
Dayrell-Hart
E
E
Meier
C
C
Vandevelde
M
M
Zurbriggen
A
A
D000818:Animals; D000906:Antibodies / Q000097:blood*; D000954:Antigens, Surface / Q000276:immunology*; D001921:Brain / Q000276:immunology*; D002478:Cells, Cultured; D004285:Dogs; D006801:Humans; D008163:Luminescent Measurements; D051379:Mice; D009422:Nervous System Diseases / Q000276:immunology
D000906:Antibodies; D000954:Antigens, Surface